Laimei Pharmaceutical announced that Qiu Yu, a shareholder holding 5% or more of the company's shares, holds 111 million shares, accounting for 10.48% of the total share capital. Due to the overdue pledge repurchase debt, Guohai Securities plans to continue to dispose of 54 shares through centralized bidding in accordance with the court's “Notice of Assistance in Enforcement”. The reduction period is within 3 months from the date of disclosure of the announcement, and the amount of holdings reduction for 90 consecutive natural days will not exceed 1% of the company's total shares.

Laimei Pharmaceutical announced that Qiu Yu, a shareholder holding 5% or more of the company's shares, holds 111 million shares, accounting for 10.48% of the total share capital. Due to the overdue pledge repurchase debt, Guohai Securities plans to continue to dispose of 54 shares through centralized bidding in accordance with the court's “Notice of Assistance in Enforcement”. The reduction period is within 3 months from the date of disclosure of the announcement, and the amount of holdings reduction for 90 consecutive natural days will not exceed 1% of the company's total shares.